<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kahan BC</submitter><funding>Medical Research Council</funding><pagination>2106-2114</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7617336</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>330(21)</volume><pubmed_abstract>&lt;h4>Importance&lt;/h4>Transparent reporting of randomized trials is essential to facilitate critical appraisal and interpretation of results. Factorial trials, in which 2 or more interventions are assessed in the same set of participants, have unique methodological considerations. However, reporting of factorial trials is suboptimal.&lt;h4>Objective&lt;/h4>To develop a consensus-based extension to the Consolidated Standards of Reporting Trials (CONSORT) 2010 Statement for factorial trials.&lt;h4>Design&lt;/h4>Using the Enhancing the Quality and Transparency of Health Research (EQUATOR) methodological framework, the CONSORT extension for factorial trials was developed by (1) generating a list of reporting recommendations for factorial trials using a scoping review of methodological articles identified usi</pubmed_abstract><journal>JAMA</journal><pubmed_title>Reporting of Factorial Randomized Trials: Extension of the CONSORT 2010 Statement.</pubmed_title><pmcid>PMC7617336</pmcid><funding_grant_id>MC_UU_00004/07</funding_grant_id><funding_grant_id>MR/V020803/1</funding_grant_id><funding_grant_id>MC_UU_00004/09</funding_grant_id><pubmed_authors>Goulao B</pubmed_authors><pubmed_authors>Hopewell S</pubmed_authors><pubmed_authors>Birchenall M</pubmed_authors><pubmed_authors>Chan AW</pubmed_authors><pubmed_authors>Fletcher J</pubmed_authors><pubmed_authors>Little P</pubmed_authors><pubmed_authors>Hall SS</pubmed_authors><pubmed_authors>Juszczak E</pubmed_authors><pubmed_authors>Beller EM</pubmed_authors><pubmed_authors>Kahan BC</pubmed_authors><pubmed_authors>Montgomery AA</pubmed_authors><pubmed_authors>Golub RM</pubmed_authors><pubmed_authors>Elbourne D</pubmed_authors><pubmed_authors>Islam N</pubmed_authors><pubmed_authors>Zwarenstein M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Reporting of Factorial Randomized Trials: Extension of the CONSORT 2010 Statement.</name><description>&lt;h4>Importance&lt;/h4>Transparent reporting of randomized trials is essential to facilitate critical appraisal and interpretation of results. Factorial trials, in which 2 or more interventions are assessed in the same set of participants, have unique methodological considerations. However, reporting of factorial trials is suboptimal.&lt;h4>Objective&lt;/h4>To develop a consensus-based extension to the Consolidated Standards of Reporting Trials (CONSORT) 2010 Statement for factorial trials.&lt;h4>Design&lt;/h4>Using the Enhancing the Quality and Transparency of Health Research (EQUATOR) methodological framework, the CONSORT extension for factorial trials was developed by (1) generating a list of reporting recommendations for factorial trials using a scoping review of methodological articles identified usi</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Dec</publication><modification>2025-04-04T01:35:48.351Z</modification><creation>2025-04-04T01:35:48.351Z</creation></dates><accession>S-EPMC7617336</accession><cross_references><pubmed>38051324</pubmed><doi>10.1001/jama.2023.19793</doi></cross_references></HashMap>